Status:
COMPLETED
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Buprenorphine, a treatment for opioid dependence, can be mixed with naloxone, to limit abuse potential. The purpose of this study is to examine the effectiveness of buprenorphine/naloxone that is give...
Detailed Description
Buprenorphine and naloxone are often combined to decrease withdrawal symptoms in opioid dependent individuals. Buprenorphine/naloxone is usually given daily to individuals who are attempting to stop o...
Eligibility Criteria
Inclusion
- Meets diagnostic criteria for opioid dependence
- Qualifies for opioid substitution treatment (e.g., methadone)
Exclusion
- Significant psychiatric or physical disorder
Key Trial Info
Start Date :
December 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2002
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00134888
Start Date
December 1 2000
End Date
November 1 2002
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University (BPRU) Bayview Campus
Baltimore, Maryland, United States, 21224 6823